Long-term results of famciclovir for recurrent or de novo
hepatitis B virus infection after liver transplantation
Clinical Transplantation. 1999;13(6):447-452 
HBV re-infection or de-novo infection in the course of liver transplantation in patients chronically infected with HBV, HBV/HDV, or HCV
Journal of Hepatology. 2023;78:S457-S458
De novo
acute hepatitis B infection in a previously vaccinated liver transplant recipient due to a strain of HBV with a Met 133 Thr mutation in the “a” determinant
Liver. 2000;20(5):411-414
Editorial response: De novo HBV infections after liver transplantation
Liver Transplantation and Surgery. 1998;4(2):182-184
De novohepatitis B virus infection from anti-HBc-positive donors in pediatric living donor liver transplantation
Journal of Digestive Diseases. 2013;14(8):439-445
Recurrent and De Novo Glomerulonephritis After Kidney Transplantation
Core Concepts in Renal Transplantation. 2011;211-231
Recurrent and De Novo Renal Diseases After Kidney Transplantation
Chronic Kidney Disease, Dialysis, and Transplantation. 2019;651-660.e6
Recurrent and De Novo Renal Diseases After Kidney Transplantation
Chronic Kidney Disease, Dialysis, and Transplantation. 2010;580-590
Retraction: Circulating FoxP3+ regulatory T and interleukin17-producing Th17 cells actively influence HBV clearance in de novo Hepatitis B virus infected patients after orthotopic liver transplantation
PLOS ONE. 2019;14(12):e0226148
Recurrent and De Novo Diseases After Renal Transplantation
Kidney Transplantation. 2014;159-172